Polar Securities »

Pacira Pharmaceuticals shares owned by Polar Securities

Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Polar Securities from 13F filings

Historical chart of Polar Securities investment in Pacira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pacira Pharmaceuticals held by Polar Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Pharmaceuticals by Polar Securities

Quarter filed Position value Share count Share price at filing
2023-06-30 $753k 19k 40.07
2023-03-31 $9.5M 232k 40.81

More positions owned by Polar Securities

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Sprott Asset Management Physical Gold Tr (PHYS)
Interdigital Note 3.500% 6/0 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
NVIDIA Corporation (NVDA)
Home Depot (HD)
Axon Enterprise Note 0.500%12/1 (Principal)
Granite Constr Note 3.750% 5/1 (Principal)
Apple (AAPL)
Verona Pharma Sponsored Ads (VRNA)
Broadcom (AVGO)
Itron Note 1.375% 7/1 (Principal)
Tesla Motors (TSLA)
Arista Networks Com Shs (ANET)

View all positions for Polar Securities

Top funds holding Pacira Pharmaceuticals

BlackRock
Vanguard Group
Doma Perpetual Capital Management
Dimensional Fund Advisors
Renaissance Technologies
D. E. Shaw & Co
State Street Corporation
Balyasny Asset Management
American Century Companies
Goldman Sachs Group
Geode Capital Management
Impax Asset Management Group
J. Goldman & Co
Jacobs Levy Equity Management
Charles Schwab Investment Management

View all funds holding Pacira Pharmaceuticals